Allianz Asset Management
ABVX

Allianz Asset Management’s Abivax ABVX Stock Holding History

Allianz Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
1,600
-2,200
-58% -$249K ﹤0.01% 2087
2026
Q1 		$423K Sell
3,800
-1,900
-33% -$225K ﹤0.01% 1857
2025
Q4 		$769K Buy
5,700
+2,800
+97% +$306K ﹤0.01% 1766
2025
Q3 		$246K Buy
+2,900
New +$178K ﹤0.01% 1937

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allianz Asset Management's ABVX Position: Q2 2026 in Review

Allianz Asset Management reduced its Abivax (ABVX) stake by 58% in Q2 2026, selling an estimated $249K and leaving 1,600 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2087.

Allianz Asset Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $769K in Q4 2025. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Allianz Asset Management held 1,600 shares of Abivax worth $213K as of Q2 2026.
  • Allianz Asset Management sold 2,200 Abivax shares in Q2 2026, an estimated $249K.
  • Abivax made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #2087 holding.
  • Allianz Asset Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Allianz Asset Management's Abivax position peaked at $769K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.